Výběr z odborné literatury na téma cervikálního screeningu

Řazeno podle: roku | typu | 1.autora

2009

Jordan, J., Martin-Hirsch, P., Arbyn, M., Schenck, U., Baldauf, J.J., Da Silva, D., Anttila, A., Nieminen, P., Prendiville, W.: European guidelines for clinical management of abnormal cervical cytology, part 2, in: Cytopathology, 2009, vol. 20, No. 1, p. 5-16

2008

Chovanec, J., Dostálová, Z.: Karcinom hrdla děložního, in: Lékařské listy, 2008, č. 7, s. 30-33

Jordan, J., Arbyn, M., Martin-Hirsch, P., Schenck, U., Baldauf, J.J., Da Silva, D., Anttila, A., Nieminen, P., Prendiville, W.: European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1, in: Cytopathology, 2008, vol. 19, No. 6, p. 342-354

Waxman, A., Rob, L.: Screening karcinomu děložního hrdla v těhotenství - podle nejnovějších doporučení ASCCP, in: Gynekologie po promoci, 2008, č. 5, s. 24-32

2007

Blanks, R., Moss, S.M., Coleman, D.A., Swerdlow, A.J.: An examination of the role of opportunistic smear taking in the NHS cervical screening programme using data from the CSEU cervical screening cohort study, in: BJOG: An International Journal of Obstetrics and Gynaecology, 2007, vol. 114, No. 11, p. 1408-1413

Bulkmans, N., Berkhof, J., Rozendaal, L., van Kemenade, F.J., Boeke, A.J., Bulk, S., Voorhorst, F.J., Verheijen, R.H., van Groningen, K., Boon, M.E., Ruitinga, W., van Ballegooijen, M., Snijders, P.J., Meijer, C.J.: Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial, in: Lancet, 2007, vol. 370, No. 9601, p. 1740-1742

Evropská společnost gynekologické onkologie, .: Vyjádření k očkování proti karcinomu děložního hrdla, in: Gynekologie po promoci, 2007, č. 5, s. 67

Kotaniemi-Talonen, L., Nieminen, P., Hakama, M., Seppänen, J., Ikkala, J., Martikainen, J., Tarkkanen, J., Toivonen, T., Anttila, A.: Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland, in: European Journal of Cancer, 2007, vol. 43, No. 1, p. 169-174

Paavonen, J., Jenkins, D., Bosch, F.X., Naud, P., Salmerón, J., Wheeler, C.M., Chow, S.N., Apter, DL., Kitchener, H.C., Castellsague, X., de Carvalho, N.S., Skinner, S.R., Harper, D.M., Hedrick, J.A., Jaisamrarn, U., Limson, G.A., Dionne, M., Quint, W., Spiessens, B., Peeters, P., Struyf, F., Wieting, S.L., Lehtinen, M.O., Dubin, G.: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial, in: Lancet, 2007, vol. 369, No. 9580, p. 2161-2170

Smith, J., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., Clifford, G.M.: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update, in: International Journal of Cancer, 2007, vol. 121, No. 3, p. 621-632

Tachezy, R., Rob, L.: Skrínink pro prevenci karcinomu děložního hrdla v České republice, in: Časopis lékařů českých, 2007, roč. 146, č. 12, s. 939-944

Tachezy, R., Rob, L.: Cervical cancer screening in the Czech Republic, in: Collegium Antropologicum, 2007, vol. 31, No. Suppl. 2, p. 27-29

2006

Anttila, A., Hakama, M., Kotaniemi-Talonen, L., Nieminen, P.: Alternative technologies in cervical cancer screening: a randomised evaluation trial, in: BMC Public Health, 2006, vol. 6, No. 252

Davies, P., Arbyn, M., Dillner, J., Kitchener, H.C., Meijer, C.J., Ronco, G., Hakama, M.: A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening, in: International Journal of Cancer, 2006, vol. 118, No. 4, p. 791-796

Dvořák, V., Ondruš, J.: Nové perspektivy prevence rakoviny děložního hrdla, in: Praktická gynekologie, 2006, roč. 10, č. 5, s. 198

Freitag, P.: Klinický význam HPV-testu, in: Praktická gynekologie, 2006, roč. 10, č. 2, s. 71-73

Garnett, G., Kim, J.J., French, K., Goldie, S.J.: Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes, in: Vaccine, 2006, vol. 24, No. Suppl 3, p. 178-186

Goldie, S., Goldhaber-Fiebert, J.D., Garnett G.P.: Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling, in: Vaccine, 2006, vol. 24, No. Suppl 3, p. 155-163

Goldie, S., Kim, J.J., Myers, E.: Chapter 19: Cost-effectiveness of cervical cancer screening, in: Vaccine, 2006, vol. 24, No. Suppl 3, p. 164-170

Kobilková, M., Beková, A., Janoušek, M., Strunová, M.: Výsledky pokusů o snížení incidence rakoviny cervixu, in: Praktická gynekologie, 2006, roč. 10, č. 5, s. 186-189

Stanley, M.: Human papillomavirus vaccines, in: Reviews in Medical Virology, 2006, vol. 16, No. 3, p. 139-149

2005

Bray, F., Carstensen, B., Møller, H., Zappa, M., Zakelj, M.P., Lawrence, G., Hakama, M., Weiderpass, E.: Incidence trends of adenocarcinoma of the cervix in 13 European countries, in: Cancer Epidemiology Biomarkers & Prevention, 2005, vol. 14, No. 9, p. 2191-2199

Dušek, L., Mužík, J.., Kubásek, M.., Koptíková, J.., Žaloudík, J.., Vyzula, R.: Epidemiologie zhoubných nádorů v České republice, in: http://www.svod.cz Masarykova univerzita, Brno 2005, ISSN 1802–8861

International Agency for Research on Cancer, .: IARC Handbooks of Cancer Prevention, Volume 10: Cervix Cancer Screening. IARC Press, Lyon 2005

Rokyta, Z., Bouda, J., Kokeš, V.: Poznámky ke screeningu rakoviny děložního hrdla, in: Gynekolog, 2005, č. 2, s. 60-67

2004

Anttila, A., Ronco, G., Clifford, G., Bray, F., Hakama, M., Arbyn, M., Weiderpass, E.: Cervical cancer screening programmes and policies in 18 European countries, in: British Journal of Cancer, 2004, vol. 91, No. 5, p. 935-941

Havránková, A., Ondruš, J.: Kolposkopická nomenklatura, in: Praktická gynekologie, 2004, roč. 8, č. 4, s. 29-30

Monsonego, J., Bosch, F.X., Coursaget, P., Cox, JT., Franco, E., Frazer, I., Sankaranarayanan, R., Schiller, J., Singer, A., Wright, T.C. Jr., Kinney, W., Meijer, C.J., Linder, J., McGoogan, E., Meijer, C.: Cervical cancer control, priorities and new directions, in: International Journal of Cancer, 2004, vol. 108, No. 3, p. 329-333

Muñoz, N., Bosch, F.X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K.V., Meijer, C.J.: Against which human papillomavirus types shall we vaccinate and screen? The international perspective, in: International Journal of Cancer, 2004, vol. 111, No. 2, p. 278-285

Nieminen, P., Vuorma S., Viikki M., Hakama M., Anttila A.: Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer, in: BJOG: An International Journal of Obstetrics and Gynaecology, 2004, vol. 111, No. 8, p. 842-848

Ondruš, J.: Současný stav plánovaného screeningu karcinomu děložního hrdla v ČR, in: Praktická gynekologie, 2004, roč. 8, č. 4, s. 36-37

Rokyta, Z., Bouda, J.: Význam malých odběrů tkáně v diagnostice cervikálních lézí, in: Praktická gynekologie, 2004, roč. 8, č. 4, s. 38-39

Tjalma, W., Arbyn, M., Paavonen, J., van Waes, T.R., Bogers, J.J.: Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer, in: International Journal of Gynecological Cancer, 2004, vol. 14, No. 5, p. 751-761

Vernerová, Z.: Problematika cervikálních lézí z pohledu patologa.Problematika cervikálních lézí z pohledu patologa, in: Praktická gynekologie, 2004, roč. 8, č. 4, s. 40-42

2003

Nieminen, P., Hakama M., Viikki M., Tarkkanen J., Anttila A.: Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year, in: International Journal of Cancer, 2003, vol. 103, No. 3, p. 422-426

Sasieni, P., Adams, J., Cuzick, J.: Benefit of cervical screening at different ages: evidence from the UK audit of screening histories, in: British Journal of Cancer, 2003, vol. 89, No. 1, p. 88-93

Wright, T., Cox, J.T., Massad, L.S., Carlson, J., Twiggs, L.B., Wilkinson, E.J.: 2001 Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia, in: Journal of Lower Genital Tract Disease, 2003, vol. 7, No. 3, p. 154-167

2002

Nieminen, P., Hakama M., Tarkkanen J., Anttila A.: Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland, in: International Journal of Cancer, 2002, vol. 99, No. 5, p. 732-736

Solomon, D., Davey, D., Kurman, R., Moriarty, A., O'Connor, D., Prey, M., Raab, S., Sherman, M., Wilbur, D., Wright, T. Jr., Young, N.: The 2001 Bethesda System: terminology for reporting results of cervical cytology, in: Journal of the American Medical Association, 2002, vol. 287, No. 16, p. 2114-2119

van den Akker-van Marle, M., van Ballegooijen, M., van Oortmarssen, G.J., Boer, R., Habbema, J.D.: Cost-effectiveness of cervical cancer screening: comparison of screening policies, in: Journal of the National Cancer Institute, 2002, vol. 94, No. 3, p. 193-204

2000

Nanda, K., McCrory, D.C., Myers, E.R., Bastian, L.A., Hasselblad, V., Hickey, J.D., Matchar, D.B.: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review, in: Annals of Internal Medicine, 2000, vol. 132, No. 10, p. 810-819

Payne, N., Chilcott J., McGoogan E.: Liquid-based cytology in cervical screening: a rapid and systematic review, in: Health Technology Assessment, 2000, vol. 4, No. 18, p. 1-73

1999

Anttila, A., Pukkala, E., Söderman, B., Kallio, M., Nieminen, P., Hakama, M.: Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence, in: International Journal of Cancer, 1999, vol. 83, No. 1, p. 59-65

Nieminen, P., Kallio, M., Anttila, A., Hakama, M.: Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study, in: International Journal of Cancer, 1999, vol. 83, No. 1, p. 55-58

Quinn, M., Babb, P., Jones, J., Allen, E.: Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics, in: BMJ, 1999, vol. 318, No. 7188, p. 904-908

Tabrizi, S., Fairley, C.K., Chen, S., Borg, A.J., Baghurst, P., Quinn, M.A., Garland, S.M.: Epidemiological characteristics of women with high grade CIN who do and do not have human papillomavirus, in: Br J Obstet Gynaecol, 1999, vol. 106, No. 3, p. 252-257

ter Hamsel, B., Smedts, F., Kuijpers, J., van Muyden, R., Oosterhuis, W., Quint, W.: Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia, in: Obstetrics & Gynecology, 1999, vol. 93, No. 1, p. 46-50

1998

Vassilakos, P., de Marval, F., Muñoz, M., Broquet, G., Campana, A.: Human papillomavirus (HPV) DNA assay as an adjunct to liquid-based Pap test in the diagnostic triage of women with an abnormal Pap smear, in: International Journal of Gynecological Cancer, 1998, vol. 61, No. 1, p. 45-50

Zhou, X.: Correcting for verification bias in studies of a diagnostic test's accuracy, in: Statistical Methods in Medical Research, 1998, vol. 7, No. 4, p. 337-353

1997

Chock, C., Irwig, L., Berry, G., Glasziou, P.: Comparing dichotomous screening tests when individuals negative on both tests are not verified, in: Journal of Clinical Epidemiology, 1997, vol. 50, No. 11, p. 1211-1217

1996

Kok, M., Boon, M.E.: Consequences of neural network technology for cervical screening: increase in diagnostic consistency and positive scores, in: Cancer, 1996, vol. 78, No. 1, p. 112-117